Regencell Bioscience Holdings Ltd (RGC)
4.96
-0.26
(-4.98%)
USD |
NASDAQ |
Apr 19, 10:08
Regencell Bioscience Holdings Shareholders Equity (Quarterly): 12.03M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 12.03M |
| December 31, 2022 | 14.66M |
| December 31, 2022 | 14.66M |
| June 30, 2022 | 17.07M |
| December 31, 2021 | 19.70M |
| Date | Value |
|---|---|
| December 31, 2021 | 19.70M |
| June 30, 2021 | -3.998M |
| December 31, 2020 | -2.985M |
| December 31, 2020 | -2.985M |
| June 30, 2020 | -2.651M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.998M
Minimum
Jun 2021
19.70M
Maximum
Dec 2021
8.519M
Average
13.34M
Median
Shareholders Equity (Quarterly) Benchmarks
| Global Pharmatech Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.62M |
| Total Liabilities (Quarterly) | 0.6323M |